Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate Newbold

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
European Thyroid Journal|July 10, 2023
Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practiceJaume Capdevila, Desiree' Deandreis, Cosimo Durante, et al.
BMC Cancer|June 16, 2019
Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre UK single arm phase II trialSarah R Brown, Andrew Hall, Hannah L Buckley, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 26, 2010
The value of magnetic resonance imaging in target volume delineation of base of tongue tumours--a study using flexible surface coilsMerina Ahmed, Maria Schmidt, Aslam Sohaib, et al.
European Thyroid Journal|March 29, 2021
Medullary Thyroid Cancer Patient's Assessment of Quality of Life Tools: Results from the QaLM StudyLaura Moss, Catrin Cox, Jonathan Wadsley, et al.
Journal for Immunotherapy of Cancer|June 9, 2021
On-treatment immune prognostic score for patients with relapsed and/or metastatic head and neck squamous cell carcinoma treated with immunotherapyPablo Nenclares, Lucinda Gunn, Heba Soliman, et al.
Clinical and Translational Radiation Oncology|February 6, 2018
Incorporating spatial dose metrics in machine learning-based normal tissue complication probability (NTCP) models of severe acute dysphagia resulting from head and neck radiotherapyJamie Dean, Kee Wong, Hiram Gay, et al.
Cancer|April 16, 2018
Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT)Lori J Wirth, Makoto Tahara, Bruce Robinson, et al.
Advances in Radiation Oncology|April 29, 2024
Measurement and Incorporation of Laryngeal Motion Using cine-MRI on an MR-Linear Accelerator to Generate Radiation Therapy Plans for Early-stage Squamous Cell Cancers of the GlottisAmit Gupta, Dualta McQuaid, Alex Dunlop, et al.
British Journal of Cancer|November 25, 2016
Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neckLiam Welsh, Rafal Panek, Angela Riddell, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 28, 2023
The Role of Pretherapy Quantitative Imaging and Dosimetry in Radioiodine Therapy for Advanced Thyroid CancerJan Taprogge, Carla Abreu, Siraj Yusuf, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
European Thyroid Journal|July 10, 2023
Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practiceJaume Capdevila, Desiree' Deandreis, Cosimo Durante, et al.
BMC Cancer|June 16, 2019
Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre UK single arm phase II trialSarah R Brown, Andrew Hall, Hannah L Buckley, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 26, 2010
The value of magnetic resonance imaging in target volume delineation of base of tongue tumours--a study using flexible surface coilsMerina Ahmed, Maria Schmidt, Aslam Sohaib, et al.
European Thyroid Journal|March 29, 2021
Medullary Thyroid Cancer Patient's Assessment of Quality of Life Tools: Results from the QaLM StudyLaura Moss, Catrin Cox, Jonathan Wadsley, et al.
Journal for Immunotherapy of Cancer|June 9, 2021
On-treatment immune prognostic score for patients with relapsed and/or metastatic head and neck squamous cell carcinoma treated with immunotherapyPablo Nenclares, Lucinda Gunn, Heba Soliman, et al.
Clinical and Translational Radiation Oncology|February 6, 2018
Incorporating spatial dose metrics in machine learning-based normal tissue complication probability (NTCP) models of severe acute dysphagia resulting from head and neck radiotherapyJamie Dean, Kee Wong, Hiram Gay, et al.
Cancer|April 16, 2018
Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT)Lori J Wirth, Makoto Tahara, Bruce Robinson, et al.
Advances in Radiation Oncology|April 29, 2024
Measurement and Incorporation of Laryngeal Motion Using cine-MRI on an MR-Linear Accelerator to Generate Radiation Therapy Plans for Early-stage Squamous Cell Cancers of the GlottisAmit Gupta, Dualta McQuaid, Alex Dunlop, et al.
British Journal of Cancer|November 25, 2016
Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neckLiam Welsh, Rafal Panek, Angela Riddell, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 28, 2023
The Role of Pretherapy Quantitative Imaging and Dosimetry in Radioiodine Therapy for Advanced Thyroid CancerJan Taprogge, Carla Abreu, Siraj Yusuf, et al.
Pageof 8